HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differential cytotoxicity to human lung normal diploid, virus-transformed and carcinoma cells by the antitumor antibiotics, auromomycin and macromomycin, and their non-protein chromophores.

Abstract
With the use of three human lung cultured cell lines: normal diploid fibroblasts (WI38), their SV40-transformants (VA13) and carcinoma cells (A549), whose doubling times were similar, the cytotoxicity of the protein antitumor antibiotics, auromomycin (AUR) and macromomycin (MCR), was studied by colony formation method. The susceptibilities of the three cell lines to these antibiotics were in the order: WI38 less than VA13 less than A549. This differentiality in the cytotoxic effect was similar between AUR and MCR. The differential cytotoxic effect did not depend on cell densities of each cell line at the time of the antibiotic-treatment. Alcohol-extracted chromophores of the antibiotics also showed a similar differential cytotoxic effect, while the apo-proteins of the antibiotics showed no cytotoxicity. It is concluded that the differential cytotoxic effect of AUR and MCR to normal, transformed and carcinoma cells is attributed to the chromophore moiety and the protein moiety is not involved in this effect.
AuthorsN Miwa, S Mizuno, S Okamoto
JournalThe Journal of antibiotics (J Antibiot (Tokyo)) Vol. 36 Issue 6 Pg. 715-20 (Jun 1983) ISSN: 0021-8820 [Print] England
PMID6307960 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Antibiotics, Antineoplastic
  • Peptides
  • auromomycin
Topics
  • Anti-Bacterial Agents
  • Antibiotics, Antineoplastic (toxicity)
  • Cell Cycle (drug effects)
  • Cell Line
  • Cell Survival (drug effects)
  • Cell Transformation, Neoplastic
  • Humans
  • Lung (drug effects, embryology)
  • Lung Neoplasms (physiopathology)
  • Peptides (toxicity)
  • Simian virus 40 (genetics)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: